11/20
08:00 am
atrc
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/7
08:00 am
atrc
AtriCure to Participate in the Stifel 2024 Healthcare Conference
Low
Report
AtriCure to Participate in the Stifel 2024 Healthcare Conference
11/1
08:17 am
atrc
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]
Medium
Report
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]
10/30
02:16 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.
10/30
12:21 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.
10/30
11:28 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.
10/30
10:08 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
10/30
08:00 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $34.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $34.00 to $40.00. They now have a "buy" rating on the stock.
10/29
11:54 pm
atrc
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript [Seeking Alpha]
10/29
04:01 pm
atrc
AtriCure Reports Third Quarter 2024 Financial Results
High
Report
AtriCure Reports Third Quarter 2024 Financial Results
10/28
08:00 am
atrc
AtriCure to Participate in the UBS Global Healthcare Conference
Low
Report
AtriCure to Participate in the UBS Global Healthcare Conference
10/16
02:11 pm
atrc
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device [Yahoo! Finance]
Low
Report
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device [Yahoo! Finance]
10/15
08:00 am
atrc
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
Low
Report
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
10/13
09:49 am
atrc
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago [Yahoo! Finance]
Low
Report
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago [Yahoo! Finance]
10/8
08:00 am
atrc
AtriCure to Announce Third Quarter 2024 Financial Results
Medium
Report
AtriCure to Announce Third Quarter 2024 Financial Results
10/1
08:00 am
atrc
AtriCure Receives CE-Mark for the EnCompass® Clamp
Low
Report
AtriCure Receives CE-Mark for the EnCompass® Clamp
9/18
10:52 am
atrc
Here's Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) [Yahoo! Finance]
Low
Report
Here's Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) [Yahoo! Finance]
9/16
08:39 am
atrc
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? [Yahoo! Finance]
Medium
Report
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? [Yahoo! Finance]
9/14
02:08 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
9/4
02:05 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
8/28
02:53 pm
atrc
Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research [Yahoo! Finance]
Low
Report
Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research [Yahoo! Finance]
8/28
01:32 pm
atrc
AtriCure's Shares Likely to Benefit From New AtriClip Device Sales [Yahoo! Finance]
Low
Report
AtriCure's Shares Likely to Benefit From New AtriClip Device Sales [Yahoo! Finance]
8/28
07:28 am
atrc
AtriClip FLEX-Mini device treatment begins with first patient [Yahoo! Finance]
Neutral
Report
AtriClip FLEX-Mini device treatment begins with first patient [Yahoo! Finance]
8/27
11:05 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Neutral
Report
AtriCure, Inc. (NASDAQ: ATRC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
8/27
08:00 am
atrc
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
Low
Report
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device